While Berkshire Hathaway’s $28 billion acquisition of H.J. Heinz and the $11 billion merger between American Airlines and US Airways may have stolen the transactional spotlight Thursday, Cardinal Health, the nation’s second-largest drug wholesaler, announced a big deal of its own on Thursday: the $2.1 billion acquisition of home health care delivery products provider AssuraMed.
Paul Bird, cochair of Debevoise & Plimpton’s corporate department and M&A group, is advising AssuraMed on the sale along with employee benefits partner Jonathan Lewis, private equity partner Kevin Rinker, and tax partner David Schnabel.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
